| Code | 9813C | ||||||||||
| MA number | 50/0396/18-S | ||||||||||
| Product Form: | tbl 90x40 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Farmak International Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 50 - DIURETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 11.12.2018 |
| Pediatric warnings: | Yes |
| Dokument: |
VHS_Furosemid Xantis 40 mg.pdf
|
| Dokument: |
VHS_súhrn_Furosemid Xantis 40 mg.pdf
|
| SPC: |
SPC_Furosemid FMK 40 mg_05.2025.pdf
|
| PIL: |
PIL_Furosemid FMK 40 mg_05.2025.pdf
|
| Safety feature | Yes |
| Data update: | 31.07.2023 |
